Caris Biorepository Research Protocol
Hematopoietic Malignancies
Solid Tumor
18 Years and older, Male and Female
Summary
The Biorepository for Caris Life Sciences is designed for the purpose of making quality
biospecimens and associated clinical data available for research studies related to advancing
precision medicine and improving care for patients.
The Caris Biorepository is a repository of prospectively collected biological specimens and
associated clinical and demographic data gathered from multiple sources to be stored, used
and shared for research. Caris Life Sciences will maintain the data and specimens and will
control access to and use of the information and specimens by multiple individuals for
multiple purposes which may evolve over time.
Objectives
The Caris Biorepository is an effort toward defining the future of medicine incorporating the
discoveries of the genomic era by providing physicians, researchers and scientists access to
quality human specimens and data aimed at improving human health and fighting disease. This
will be accomplished through acquiring and sharing valuable biospecimen information and
clinical outcomes in a collaborative, secure environment. The Caris Biorepository will bridge
the gap and correlate human specimens with clinical and specimen data valuable to multiple
and varying entities interested in advancing science with precision medicine by targeting
disease treatments.
The objective of this project is to develop and implement a state-of-the-science
Biorepository that ensures molecular integrity and clinical relevance of human biospecimens
used in research and clinical medicine. The Caris Biorepository will also provide vital
biospecimens and data to internal researchers and external research collaborators such as
government, academia and industry collaborators for the use of drug development discoveries,
clinically relevant research trials, publications and posters, and the implementation of
future healthcare policies. This project may also impact characterization of trends in
practice patterns and their relation to patient outcomes as well as the economic implications
of differing evaluation, treatment and management paradigms.
Eligibility
- 18 years of age or older
- Capacity to provide informed consent
Treatment Sites in Georgia
**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts...
Click here to learn more about clinical trials.